Medi-Cal Pharmacy (Rx) – UPDATE – Removal of Basaglar (Insulin Glargine)
| Date: | August 20, 2026 |
| From: | Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) |
| To: | Health Plan Practitioners, Facilities, and Hospitals |
| Type: | Informational/Educational |
| Subject: | Medi-Cal Pharmacy (Rx) – UPDATE – Removal of Basaglar (Insulin Glargine) |
| Business: | Medi-Cal Managed Care |
*POSTPONED to 11/01/2026*
Effective August 9, 2026, Medi-Cal Rx will no longer cover Basaglar (Insulin Glargine). This drug will be removed from the Medi-Cal Rx Contract Drugs List (CDL).
- Basaglar will deny with at the pharmacy with Reject Code 606 – Brand Drug/Specific Labeler Code Required.
- CDL covered alternative is Lantus (insulin glargine) or insulin glargine-yfgn.
- Prescribers may submit a prior authorization to Medi-Cal Rx with medical justification for the consideration for use of Basaglar.
For additional detailed information, please visit weblink: https://medicalrx.dhcs.ca.gov/cms/medicalrx/staticassets/documents/provider/2026/06_A_Coming_
Soon_Basaglar_Removed_from_CDL_Effective08092026.pdf
If you have any further questions, please contact your Provider Services Representative, or call our Customer Service Department at 1-888-936-PLAN (7526). You may also visit https://www.hpsj.com/alerts/ for online access to the documents shared. The most recent information about Health Plan and our services is always available on our website www.hpsj-mvhp.org
